6 news items
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GRTS
9 May 24
. Food and Drug Administration. They are currently limited by Federal law to investigational use, and no representation is made as to their safety
What's Going On With Small Cap Cancer Vaccine Focused Gritstone Bio Stock On Tuesday?
GRTS
2 Apr 24
manufacturing success rate).
GRANITE demonstrated a favorable safety and tolerability profile. Common AEs were mild systemic and local effects
Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
GRTS
1 Apr 24
that actual results, levels of activity, safety, performance or events and circumstances could differ materially from those expressed or implied
Gritstone bio Announces Proposed Public Offering
GRTS
1 Apr 24
, the Company can give no assurance that such expectations will prove to be correct. Readers are cautioned that actual results, levels of activity, safety
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
GRTS
1 Apr 24
. Safety and Tolerability GRANITE demonstrated a favorable safety and tolerability profile
gm8fwqgt3qg0xe b1sbq70001ufk
GRTS
1 Mar 24
the efficacy, safety, and immunogenicity of the Gritstone next-generation COVID-19 vaccine candidate with an approved COVID-19 vaccine
- Prev
- 1
- Next